A cytoplasmic motif in HLA-E that drives clathrin-mediated endocytosis and VCP-associated postendocytic trafficking

W Wanlin He (Center for Immuno-Oncology, Nuffield Department of Medicine, University of Oxford) A Andreas Damianou (Target Discovery Institute, Centre for Medicines Discovery, Nuffield Department of Medicine, University of Oxford) I Iolanda Vendrell K Klaus Früh D Daowen I. Yin (Department of Structural and Molecular Biology, Division of Biosciences, University College London) F Frances M. Brodsky (Department of Structural and Molecular Biology, Division of Biosciences, University College London) B Benedikt M. Kessler S Simon Brackenridge (Center for Immuno-Oncology, Nuffield Department of Medicine, University of Oxford) P Persephone Borrow (Center for Immuno-Oncology, Nuffield Department of Medicine, University of Oxford) G Geraldine M. Gillespie (Center for Immuno-Oncology, Nuffield Department of Medicine, University of Oxford) A Andrew J. McMichael (Center for Immuno-Oncology, Nuffield Department of Medicine, University of Oxford)

Abstract

Human Leukocyte Antigen E (HLA-E) is a nonclassical MHC class I molecule that exhibits dual immunological functions in regulating natural killer (NK) cells and T cells through unusual trafficking patterns. We previously reported that HLA-E surface expression is low and transient due to its cytoplasmic tail and dominant VL9 peptide, making it a dynamic indicator of cellular status for NK cell surveillance. Here, we identify a sequence motif in the HLA-E cytoplasmic tail that enables rapid internalization via clathrin-mediated endocytosis (CME) through interaction with the adaptor protein 2 (AP-2) complex. Following internalization, HLA-E is routed to endosomes, where the same cytoplasmic motif and peptide loading together facilitate its reappearance on the cell surface—a process influenced by valosin-containing protein (VCP). Our findings reveal previously unrecognized endosomal trafficking pathways and regulatory mechanisms that distinguish HLA-E from classical HLA class I molecules, with broad implications for understanding the immunoregulatory roles of HLA-E.

Article Details

Volume / Issue Vol. 122, Issue 43
Published October 28, 2025
ISSN 0027-8424
Publisher National Academy of Sciences

Authors (11)

W

Wanlin He

Center for Immuno-Oncology, Nuffield Department of Medicine, University of Oxford

A

Andreas Damianou

Target Discovery Institute, Centre for Medicines Discovery, Nuffield Department of Medicine, University of Oxford

I

Iolanda Vendrell

K

Klaus Früh

D

Daowen I. Yin

Department of Structural and Molecular Biology, Division of Biosciences, University College London

F

Frances M. Brodsky

Department of Structural and Molecular Biology, Division of Biosciences, University College London

B

Benedikt M. Kessler

S

Simon Brackenridge

Center for Immuno-Oncology, Nuffield Department of Medicine, University of Oxford

P

Persephone Borrow

Center for Immuno-Oncology, Nuffield Department of Medicine, University of Oxford

G

Geraldine M. Gillespie

Center for Immuno-Oncology, Nuffield Department of Medicine, University of Oxford

A

Andrew J. McMichael

Center for Immuno-Oncology, Nuffield Department of Medicine, University of Oxford